|
|
|
|
|
|
Sponsors and Collaborators: |
Cancer Institute of New Jersey National Cancer Institute (NCI) |
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00176540 |
RATIONALE: Dextromethorphan may help relieve fatigue in patients with cancer.
PURPOSE: This clinical trial is studying how well dextromethorphan works in treating patients with fatigue caused by cancer.
Condition | Intervention |
Fatigue Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific |
Drug: dextromethorphan hydrobromide |
MedlinePlus related topics: | Cancer |
Drug Information available for: | Dextromethorphan Dextromethorphan hydrobromide Levomethorphan Racemethorphan |
Study Type: | Interventional |
Study Design: | Supportive Care, Open Label |
Official Title: | A Pilot Trial to Evaluate the Effects of Dextromethorphan in Patients Suffering From Cancer-Related Fatigue |
Estimated Enrollment: | 30 |
Study Start Date: | March 2004 |
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter, open-label, pilot study.
Patients receive oral dextromethorphan hydrobromide 3 times a day on days 1-7. Treatment repeats weekly for up to 3 weeks in the absence of disease progression or unacceptable toxicity.
PROJECTED ACCRUAL: A total of 30 patients will be accrued for this study.
Ages Eligible for Study: | 12 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Diagnosis of malignancy
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, New Jersey | |||||
Cancer Institute of New Jersey at Hamilton | |||||
Hamilton, New Jersey, United States, 08690 | |||||
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School | |||||
New Brunswick, New Jersey, United States, 08903 |
Cancer Institute of New Jersey |
National Cancer Institute (NCI) |
Principal Investigator: | Susan Goodin, PharmD | Cancer Institute of New Jersey |
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
Study ID Numbers: | CDR0000539650, CINJ-5017v2, CINJ-4598, CINJ-NJ11005 |
First Received: | September 12, 2005 |
Last Updated: | August 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00176540 |
Health Authority: | United States: Federal Government |
|
|
|
|
|